Just a little over a year after announcing a plan to spin off its spine and dental businesses, Zimmer Biomet has completed the separation, culminating in the creation of a standalone public ...

In 2021, Zimmer Biomet announced its intentions to spinoff ZimVie (Dental and Spine segment accounting for 12.87% of revenue in 2021) which is expected to be completed by March 1st, 2022.

According to Zimmer Biomet, the inclusion of this French spine device maker will not only bolster its presence in the $10 billion global spine market by significantly expanding its portfolio of ...

Zimmer Biomet Holdings, Inc. ZBH, a global leader in musculoskeletal healthcare, recently launched PrimaGen Advanced Allograft. The product, which falls under its spine segment, has been designed ...

While many of its peers in the medtech industry are proceeding with caution amid the fluctuating market conditions of 2022, Zimmer Biomet, for one, is putting the pedal to the metal. First up on ...

ZimVie is a spin-off of the dental and spine business units of Zimmer Biomet. The Company is a leading player with #5 and #6 positions in the dental and spine market respectively. The Company with ...

Zimmer Biomet's Spine Division is headquartered in Broomfield, offering spine-related medical-device products as well as training and clinical support to surgeons. In a statement, It said both ...

Zimmer Biomet expects to establish critical mass in spine and dental that will position the company to compete effectively and gain share in these significant markets. Zacks Investment Research ...

WASHINGTON (dpa-AFX) - Musculoskeletal healthcare firm Zimmer Biomet Holdings Inc. (ZBH) announced Friday its intention to spin off its Spine and Dental businesses into a new and independent ...

According to Zimmer Biomet, the inclusion of this French spine device maker will not only bolster its presence in the $10 billion global spine market by significantly expanding its portfolio of ...

Zimmer Biomet announced that it plans to spin off its dental and spine businesses into a new company as it plans to focus on its musculoskeletal healthcare business going forward. The deal should be ...